Table 2.

Correlation between LMR and TILs/TAM ratio and clinicopathological characteristics

	LMR			CD45RO/CD68 ratio			CD8/CD68 ratio			CD4/CD68 ratio
	Low	High	p	Low	High	p	Low	High	p	Low	High	p
Age (years)			0.787			0.250			0.683			0.455
≤60	72	52		87	37		98	26		97	27
>60	54	42		74	22		78	18		79	17
Gender			0.998			0.303			0.893			0.636
Male	67	50		89	28		94	23		95	22
Female	59	44		72	31		82	21		81	22
KPS			0.216			0.253			0.651			0.407
<80	39	22		48	13		50	11		51	10
≥80	87	72		113	46		126	33		125	34
Tumor location			0.896			0.382			0.054			0.464
Upper	16	10		21	5		21	5		23	3
Middle	50	38		67	21		77	11		71	17
Lower	60	46		73	33		78	28		82	24
Tumor differentiation			0.016			0.006			0.248			0.036
Well	44	44		54	34		67	21		64	24
Moderate	46	38		67	17		72	12		74	10
Poor	36	12		40	8		37	11		38	10
Tumor length			0.023			0.300			0.629			0.408
≤4 cm	68	65		94	39		105	28		104	29
>4 cm	58	29		67	20		71	16		72	15
Perineural invasion			0.702			0.195			0.602			1.000
No	123	91		155	59		170	44		171	43
Yes	3	3		6	0		6	0		5	1
Vascular invasion			0.701			0.194			0.349			0.349
No	121	92		154	59		169	44		169	44
Yes	5	2		7	0		7	0		7	0
Treatment			0.820			0.178			0.161
Surgery only	61	41		77	25		85	17		84	18	0.330
Adjuvant chemotherapy	25	21		30	16		32	14		37	9
Adjuvant radiation	23	16		26	13		30	9		27	12
Adjuvant chemoradiation	17	16		28	5		29	4		28	5
Recurrence			0.319			<0.001			0.130			0.016
No	19	19		19	19		27	11		25	13
Yes	107	75		142	40		149	33		151	31

Values in bold signify p < 0.05

LMR lymphocyte-to-monocyte ratio, TILs tumor-infiltrating lymphocytes, TAM tumor-associated macrophages